Alison Kortz
Dermatology · Schenectady, NYNPI 1619966264
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 683 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 24.2% of the total. Reporting peaked in 2022 at $3,734 and has fallen 66.2% since, to $1,263 in 2025.
Across 683 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$2K
- Novartis$2K
- Sun Pharmaceutical Industries Inc.$712
- Regeneron Healthcare Solutions, Inc.$666
- Amgen$656
- plus $4K from 19 others
What the payments were for
- Speaking & faculty fees$3002%
- Food & beverage$12,28797%
- Education$1271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 205 | $3,072 |
| Johnson & Johnson | 106 | $2,192 |
| Novartis | 108 | $1,590 |
| Sun Pharmaceutical Industries Inc. | 44 | $712 |
| Regeneron Healthcare Solutions, Inc. | 18 | $666 |
| Amgen | 37 | $656 |
| UCB, Inc. | 22 | $518 |
| E.r. Squibb & Sons, L.L.C. | 24 | $487 |
| Lilly USA, LLC | 24 | $472 |
| Sanofi | 18 | $423 |
| Helsinn Therapeutics (U.S.), Inc. | 5 | $379 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 23 | $351 |
| Arcutis Biotherapeutics, Inc. | 12 | $220 |
| Boehringer Ingelheim | 4 | $207 |
| Prugen, Inc. Pharmaceuticals | 1 | $175 |
| Incyte Corporation | 8 | $140 |
| LEO Pharma Inc. | 6 | $134 |
| Biofrontera Inc. | 4 | $86 |
| Pfizer | 4 | $73 |
| Kyowa Kirin, Inc. | 3 | $58 |
| Blueprint Medicines Corporation | 2 | $46 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Organon | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,714 in reported general payments places this provider in the 80th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $59,884 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 53 | $2,521 |
| Clobetasol Propionate | 43 | $2,197 |
| Ketoconazole | 101 | $1,828 |
| Mometasone Furoate | 46 | $1,573 |
| Tacrolimus | 11 | $1,213 |
| Triamcinolone Acetonide | 75 | $1,155 |
| Metronidazole | 24 | $906 |
| Fluorouracil | 14 | $764 |
| Doxycycline Hyclate | 63 | $759 |
| Cephalexin | 146 | $588 |
| Nystatin | 19 | $516 |
| Mupirocin | 37 | $426 |
| Spironolactone | 24 | $361 |
| Minoxidil | 33 | $346 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Schenectady
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
- Emma GuttmanNew York$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.